Categories: HealthcareNews

IllumiCare Delivers Cost-Saving Insights on Low-Value Care Directly to Providers’ Mobile Devices

BIRMINGHAM, Ala., Feb. 28, 2025 /PRNewswire/ — IllumiCare is the market leader in “nudging” healthcare providers in their EMR ordering workflow when specific opportunities arise to be more clinically and fiscally efficient. These opportunities stem from IllumiCare’s proprietary and growing library of clinical financial decision support rules and content.

Today the company announces a new way to engage clinicians to reflect on their practice habits and become better stewards of hospital resources (and patient bills). 

For years, IllumiCare has given each clinician a personal view of how they compare to their peers. That information has been delivered via a “Variations app” found on its Smart Ribbon platform. Now, IllumiCare is making this information more accessible  – each clinician’s opportunities for improvement will be delivered directly to their mobile phone via SMS message. 

“Our biggest impact comes when we make a recommendation where and when a specific decision about a specific patient is being made,” said G.T. LaBorde, CEO of IllumiCare. “Supplementing this content with a monthly mobile data push will reinforce a stewardship mindset and highlight opportunities to improve.”

The new mobile solution will launch across multiple US healthcare facilities in Q2 2025. For more information, visit www.illumicare.com.

About IllumiCare
IllumiCare was founded in Birmingham, Ala., and has helped align behavior at 350+ healthcare facilities through its foundational nudge technology. With deep experience in the clinical, financial, and technical aspects of hospital operations, IllumiCare created the Smart Ribbon, which combines actionable clinical and financial intelligence in a transcendent platform. Learn more at www.illumicare.com

View original content:https://www.prnewswire.com/news-releases/illumicare-delivers-cost-saving-insights-on-low-value-care-directly-to-providers-mobile-devices-302388855.html

SOURCE IllumiCare

Staff

Recent Posts

Cosmo Enters Scale Up Phase with 104M Revenue, 128M Cash, and Breakout AI and Dermatology Platforms

Ad hoc announcement pursuant to Art. 53 LR 2025 marks a key execution year in…

10 minutes ago

Pre-JPM Investor Pulse Signals 2026 Capital Rotation Toward “AI That Ships,” Admin Cost Takeout, and Differentiated Metabolic Assets With Special-Situations Capital Back in Scope

Preliminary, directional read of planned 88-investor sample indicates heightened proof thresholds (unit economics, reimbursement, outcomes)…

14 hours ago

Best GLP-1 Weight Loss Shot (2026): Direct Meds Reviews Prescription Access Pathways as New GLP-1 Formats Expand

LegitScript-certified telehealth platform publishes consumer analysis as searches for GLP-1 weight loss information reach record…

17 hours ago

Nutri Derma Guard Skin Tag Remover Ingredients Investigated: 2026 Analysis Examines Formulation And Consumer Disclosures

Independent investigation examines castor oil, tea tree oil, and salicylic acid formulation claims in the…

17 hours ago

SleepZee Mouth Guard Legitimacy Examined: 2026 Consumer Analysis Investigates Anti-Snoring Device Claims and Company Transparency

Independent examination investigates SleepZee's moldable customization approach, medical-grade material claims, and manufacturer disclosure practices for…

17 hours ago